GlaxoSmithKline has attempted to knock out the plaintiff’s experts in Dolin v. GlaxoSmithKline, in its latest round of Daubert motions. Wendy Dolin is suing GSK after the suicide death of her prominent lawyer husband, who had been taking the generic form of Paxil, paroxetine, an antidepressant. This case made national news just a year ago when Judge Zagel of the Northern District of Illinois held that GSK could be liable for Dolin’s death under a negligence theory, not a product liability theory, even though…
Continue reading...
Litigation
Continue reading...
- J&J, Ethicon Sued Over Surgical Stapler Misfire (subscription required)
- GSK Can’t Shake Calif. County’s Avandia False Ad Claims (subscription required)
- Pradaxa Lawsuits Raise Questions Over Clinical Trial Data Accuracy
- Firms Kick Off Benicar Diarrhea Suits Against Daiichi (subscription required)
- Mirena Birth Control Lawsuit Filings Approach 1,000 Cases
- Boston Scientific Obtryx Sling Lawsuits Consolidated for Trial
- Zoloft False Ad Suit Time-Barred, Judge Finds (subscription required)
- J&J Hid Topamax Birth Defect Risks, Philly Jury Hears (subscription required)
- Total, Endo Units Hit With
Continue reading...
Litigation
Continue reading...
- Xarelto Lawsuit Filed Over Uncontrollable Internal Bleeding
- Neomedic Cases Added to Vaginal Mesh Litigation in W.Va. Federal Court
- Endo Puts Aside $520M for Vaginal Mesh Litigation (subscription required)
- 9th Circ. Refuses to Revive Novartis Jaw Injury Litigation (subscription required)
- FTC Bags $2M False Ad Win Against Diabetes Supplement Co. (subscription required)
- J&J Mesh Suits Belong in Federal Court, 10th Circ. Told (subscription required)
- New Philly Mass Tort Program Created for Pelvic Mesh Suits (subscription required)
- J&J Wins 1
Continue reading...
Litigation
Continue reading...
- Byetta Thyroid Cancer Lawsuit Centralization Request Filed with JPML
- MDL Arguments Over Centralization of Lipitor Diabetes Cases Postponed
- Top DOJ Atty Outline Pharma Fraud Enforcement (subscription required)
- Possible Sanctions for Takeda in Actos Bladder Cancer MDL (subscription required)
- Hydroxycut False Ad Claims Must Be Clarified, Judge Says (subscription required)
- GNC Hit with Suit Claiming Diet Pills Led to Liver Damage (subscription required)
- J&J Beats $258M Risperdal Verdict in Split La. High Court (subscription required)
- Calif. Court Reverses Preemption of Medtronic
Continue reading...
The Pennsylvania Superior Court recently upheld the trial court’s ruling in Thomas v. SmithKline Beecham Corp., 27 Pa.D.&C. 5th 279 (Pa.Commw. Ct. 2012). Thomas dismissed plaintiff’s wrongful death and survival claims based on her use of the antidepressant drug Paxil during pregnancy as time barred. She ingested Paxil during her pregnancy and she was subsequently informed in 2001 that a fetal echocardiogram revealed that her fetus had congenital heart defects. Three days later she chose to undergo a therapeutic abortion at less than…
Continue reading...
Continue reading...
Litigation
Continue reading...
- Pamlab Can’t Bar Virtus’ Marketing In Unfair Competition Row (subscription required)
- Pa. Appeals Court Upholds GSK Win in Paxil Pregnancy Suit (subscription required)
- J&J Asks Pa. Court to Keep Risperdal Docs Under Seal (subscription required)
- Standing Issue Threatens 15 Zometa Suits in NJ (subscription required)
- 23andMe Hit with False Ad Suit Over DNA Tests (subscription required)
- Diageo Shells Out $81M to Settle Aussie, NZ Thalidomide Suits (subscription required)
- Generic-Reglan Suits Doomed by Catch-22, 6th Circ. Says (subscription required)
- J&J
Continue reading...
Litigation
Continue reading...
- Stryker Rejuvenate Lawsuits Filed by Nearly 1,000 Hip Patients Nationwide
- Novartis Can’t Apply NJ Punitives Cap in 3 Zometa Suits (subscription required)
- Pfizer Escapes FCA Suit Over Anti-Fungal Drug Promotions (subscription required)
- Gardasil Lawsuit Filed in France Over Side Effects of HPV Vaccine
- Judge Backs Jury Finding in J&J Body Powder Cancer Suit (subscription required)
- OxyElite Pro Class Action Filed Over False Advertising
- First Zoloft Trial in Federal MDL for Birth Defect Lawsuits to Begin Nov. 2014
- J&J Takes Innovative,
Continue reading...
Litigation
Continue reading...
- 6th Circ. Won’t Hear Appeal of Darvocet Suit Remand (subscription required)
- Okla. Supreme Court Gives Harsh Take on Abortion Drug Law (subscription required)
- Takeaways from McPhee v. DePuy’s Preemption Pronouncement (subscription required)
- Canadian Court Won’t Shrink Paxil Birth Defect Class (subscription required)
- Major Medical Device Manufacturer Agrees to Pay $13.2 Million to Settle Foreign Corrupt Practices Act (FCPA) Charges
- Dow Seeks En Banc Review of Cancer Cluster Suit (subscription required)
- Lumina Diet Supplement Class Action Stays in Fed. Court
Continue reading...
British drugmaker GlaxoSmithKline (GSK) announced on July 25th that it would pay $229 million to resolve lawsuits brought by eight U.S. states related to improper marketing of its diabetes drug Avandia (rosiglitazone). In a regulatory filing, GSK said the settlement was within provisions it had previously set aside for litigation, and also resolved claims brought by the Attorney General of Louisiana involving other GSK products.
The announcement by GSK explained that the settlements had been undertaken in order to avoid lengthy trials, and did…
Continue reading...
Continue reading...